Trial Information

Summary: Relapsing Remitting Multiple Sclerosis (RRMS)

People with relapsing remitting multiple sclerosis are asked to participate in a research study being conducted by NYU Hospital for Joint Diseases.

You may be eligible to participate in this study if you:

• Are between the ages of 18 and 55 inclusive
• Have had 1 documented relapse in the past year or 2 documented relapses in the past 2 years

• Have a different form of multiple sclerosis (other than RRMS)
• Have Used immunosuppressive (including Mitoxantrone (NovantroneŽ) or cytotoxic agents within 6 months prior to the screening visit.
• Previously used either of the following: natalizumab, (TysabriŽ), cladribine, laquinimod.
• Have a history of tuberculosis
• Have an infection 2 weeks prior to study start
• Have HIV or Hepatitis A,B, or C
• Have received a bone marrow transplant
• Have had major trauma surgery 2 weeks prior to study start
• Have used amiodarone within 2 years prior to screening visit.
• Have had a heart attack within the past 6 months
• Have a gastrointestinal disorder, kidney, liver or other metabolic diseases
• Have a history of drug or alcohol abuse or any major psychiatric disorder
• Are unable to undergo an MRI
• Are pregnant, breastfeeding, or intend to become pregnant during the study
• Have participated in another research study within the last 6 months

If you would like to learn more about participating in this study, please send an e-mail message using the form below.